Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-24-012924
Filing Date
2024-09-20
Accepted
2024-09-20 16:16:11
Documents
22
Period of Report
2024-11-05

Document Format Files

Seq Description Document Type Size
1 DEF 14A pahc-20241105xdef14a.htm   iXBRL DEF 14A 1599450
2 GRAPHIC pahc-20241105xdef14a_a003.jpg GRAPHIC 13940
3 GRAPHIC pahc-20241105xdef14a_a004.jpg GRAPHIC 5131
4 GRAPHIC pahc-20241105xdef14a_a019.jpg GRAPHIC 66490
5 GRAPHIC pahc-20241105xdef14a_a020.jpg GRAPHIC 64516
6 GRAPHIC pahc-20241105xdef14a_a021.jpg GRAPHIC 65898
7 GRAPHIC pahc-20241105xdef14a_a022.jpg GRAPHIC 44558
8 GRAPHIC pahc-20241105xdef14a_bg001.jpg GRAPHIC 162967
9 GRAPHIC pahc-20241105xdef14a_cg001.jpg GRAPHIC 107652
  Complete submission text file 0001558370-24-012924.txt   4030147

Data Files

Seq Description Document Type Size
10 EX-101.SCH pahc-20241105.xsd EX-101.SCH 7093
11 EX-101.DEF pahc-20241105_def.xml EX-101.DEF 51809
12 EX-101.LAB pahc-20241105_lab.xml EX-101.LAB 5378
13 EX-101.PRE pahc-20241105_pre.xml EX-101.PRE 4980
24 EXTRACTED XBRL INSTANCE DOCUMENT pahc-20241105xdef14a_htm.xml XML 364773
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-36410 | Film No.: 241313589
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)